Healthy Growth Starts Here
Frost & Sullivan’s Healthcare & Life Sciences practice has a powerhouse team of analysts and strategists covering all facets of this trillion-dollar industry.
We analyze growth opportunities and competitive positioning for our clients, based on our years of expertise, combined with the voice of the customer, to identify the best strategies to succeed in a world where disruptions are occurring due to Care Delivery Transformation, Site of Care Evolution, Payment Transition to Value-based Care, New Market Entrants, Business Model Innovation and Cutting-edge Technologies.
Our Growth Opportunity Newsletter
Book a complimentary one-hour session of Growth Pipeline Dialog™ with our experts.
Upcoming speaking engagements
Healthcare systems are undergoing dramatic structural changes that will impact every aspect of the way healthcare services are paid for and delivered, and the movement of care outside traditional settings is transforming medicine through digital health solutions.
Advanced Medical Technologies
In-depth coverage of the multitude of products and solutions used by providers across a typical clinical pathway, ranging from making a diagnosis, using the appropriate interventional or therapeutic approach and finally monitoring the subject through rehabilitation and convalescence.
To achieve continued double digit growth and mitigate risks in R&D and manufacturing, pharma companies must gather actionable intelligence that will enable them to move rapidly from quantity-based, fee-for-service model to outcomes based contracts and adopt new digital platforms.
Clinical Diagnostics & Research Tools
The industry is witnessing significant disruptions around new regulations (PAMA implementation, deployment of laboratory developed tests) and move towards decentralized testing (home & retail type settings).
Critical Trends for Healthcare Transformation
Business Models & Services
Diminishing returns on investments made towards strategies for technical innovation, are putting pressure on healthcare companies to achieve growth objectives through radically evolving their business model.
Health Data Science
Future of Industries & Outlooks
Medical Technology Disruptors
From Hospital to Home
New Technology Adoption
News, Events & Resources
These issues include tackling the diseases that lack an effective vaccine and developing new technologies and approaches to address a future pandemic. A new report from Frost & Sullivan highlights the platforms that can help companies overcome these challenges and...
Robin Joffe Appointed as Partner-Managing Director of Frost & Sullivan Middle East, Africa, and South Asia
Dubai, UAE, May 10, 2022 – With an aim to better serve an increasingly strategic customer segment, Frost & Sullivan has appointed Robin Joffe as Partner-Managing Director of its Middle East, Africa, and South Asia (MEASA) operations. He brings over 25 years of...
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines San Antonio – April 7, 2022 – Transformational forces are influencing the global contract development and...